Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
- Bertens, Daniela
- Vos, Stephanie
- Kehoe, Patrick
- Wolf, Henrike
- Nobili, Flavio
- Mendonça, Alexandre
- van Rossum, Ineke
- Hort, Jacub
- Molinuevo, Jose Luis
- Heneka, Michael
- Petersen, Ron
- Scheltens, Philip
- Visser, Pieter Jelle
Publication date
January 2019
DOI Publisher
Springer Science and Business Media LLC Language
EnglishAbstract
The diagnosis of mild cognitive impairment (MCI) refers to cognitive impairment not meeting dementia criteria. A survey among members of the American Association of Neurology (AAN) showed that MCI was considered a useful diagnosis. Recently, research criteria have been proposed for the diagnosis of Alzheimer's disease (AD) in MCI based on AD biomarkers (prodromal AD/MCI due to AD). The aim of this study was to investigate the attitudes of clinicians in Europe on the clinical utility of MCI and prodromal AD/MCI due to AD criteria. We also investigated whether the prodromal AD/MCI due to AD criteria impacted management of MCI patients
Add to ORKG